| Financial Year |
March 31 2023 |
| Monetary Funds |
891,960,684.66 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
11,991,390.00 |
| Accounts Receivable |
1,087,732,025.63 |
| Advances to Suppliers |
63,351,848.63 |
| Other Receivables |
197,892,065.20 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
113,750,814.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
91,032,011.60 |
| Other Current Assets |
193,592,917.06 |
| Total Current Assets |
3,101,275,462.13 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,544,988,806.19 |
| Long-term Equity Investment |
85,985,389.98 |
| Investment Properties |
-- |
| Fixed Assetes |
429,003,536.34 |
| Under-construction Projects |
402,151,851.93 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
840,679,806.20 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,612,269.56 |
| Deferred Income Tax Assets |
211,777,502.24 |
| Other Non-Current Assets |
279,331,561.05 |
| Sub-Total of Non-Current Assets |
4,861,902,395.02 |
| Total Assets |
7,963,177,857.15 |
| Short-Term Loans |
857,975,152.91 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
771,618,431.27 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
16,731,818.82 |
| Taxes Payable |
95,646,260.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
243,984,801.57 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
108,223,780.02 |
| Other Current Liabilities |
71,815,031.84 |
| Sub-Total of Current Liabilities |
2,220,965,686.38 |
| Long-term Loans |
923,289,404.38 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
213,802,190.75 |
| Deferred Income Tax Liabilities |
100,942,175.29 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,258,316,351.95 |
| Total Liabilities |
3,479,282,038.33 |
| Paid-In Capital(Or Share Stock) |
797,165,232.00 |
| Capital Surplus |
1,188,323,252.95 |
| Surplus Reserve |
80,660,461.68 |
| LESS:Treasury Stock |
82,421,080.00 |
| Undistributed Profits |
2,349,709,494.66 |
| Minority Stockholder's Interest |
150,458,457.53 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,333,437,361.29 |
| Owner's Equity（Stockholder's Equity） |
4,483,895,818.82 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
7,963,177,857.15 |
